Investor Relations | Business Upturn

Dr. Reddy’s Laboratories updates code for fair disclosure of price-sensitive information

Yash Agarwal — Tue, 24 Mar 2026 13:56:12 +0000

Dr. Reddy’s Laboratories has announced an update to its ‘Code of Practices and Procedures for Fair Disclosures of Un-published Price Sensitive Information’. This update aligns with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, reflecting the company’s commitment to maintaining transparency and compliance.

The revised code outlines the procedures for uniform and universal disclosure of unpublished price-sensitive information (UPSI) to avoid selective disclosure. The Chief Investor Relations Officer is tasked with ensuring that any UPSI is disseminated promptly and uniformly across all platforms, including the company’s website.

In the event of any inadvertent selective disclosure, the company is committed to making the information generally available within the time frame specified by applicable laws and regulations. The code also details the company’s approach to interacting with regulatory authorities, ensuring fair responses to queries and verification requests related to market rumours.

The company emphasises that during interactions with investors, analysts, and other stakeholders, no UPSI will be selectively disclosed. To support transparency, transcripts or recordings of investor conferences will be made available on the company’s website.

The handling of UPSI is strictly on a ‘need to know’ basis, and any inadvertent disclosure will be publicly disseminated within 24 hours. The code also defines ‘legitimate purpose’ for sharing UPSI, ensuring that it is shared only in the ordinary course of business with partners and advisors, who are then considered insiders.

A structured digital database will be maintained by the Chief Executive Officer under the Board’s supervision, recording the nature of UPSI and the identities of those sharing and receiving it. This database will be preserved for at least eight years, or longer if required by regulatory investigations.

The code is subject to review and amendment by the Board to ensure ongoing compliance with SEBI regulations and other applicable guidelines.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Kfin Technologies to hold investor meetings in Singapore on March 12

Business Desk — Mon, 09 Mar 2026 17:20:05 +0000

Kfin Technologies has scheduled investor meetings with major institutional funds in Singapore on March 12, 2026. The company will conduct one-to-one sessions with Morgan Stanley Investment Management, Nippon Life India Asset Management, Henderson Global Investors, HSBC Global Asset Management, and Lion Global Investors.

During the meetings, Kfin Technologies will make presentations aligned with materials shared on the stock exchange and company websites on February 13, 2026. The schedule is subject to change based on any exigencies that may arise.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

ICICI Bank to participate in Investec India Banks CEO Day on March 13

Business Desk — Mon, 09 Mar 2026 13:51:47 +0000

ICICI Bank will participate in investor meets scheduled across March 2026, as per a regulatory disclosure filed with the National Stock Exchange of India and BSE Limited on March 9, 2026.

The bank’s investor engagement calendar includes two group events. The first is the Investec India Banks CEO Day on March 13, 2026, which will be held in-person. This will be followed by the Morgan Stanley Virtual India Financials Seminar on March 17, 2026, conducted in virtual mode.

The bank stated that it will refer to publicly available documents during discussions at these investor meets. The disclosure was made under Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

This article is written by Business Desk and reviewed by Markets Desk before publication.